[1] |
LIU Na.
Rotavirus prevalence and rotavirus vaccine in China
[J]. CJPP, 2021, 36(5): 328-331.
|
[2] |
LIU Fang, ZHAO Qu-ming.
Assessment for myocardial ischemia related to coronary artery abnormalities in children with Kawasaki disease
[J]. CJPP, 2021, 36(5): 336-339.
|
[3] |
FAN Xue,XU Ming-guo.
Research progress in the pathogenesis and treatment of Kawasaki disease
[J]. CJPP, 2021, 36(5): 339-344.
|
[4] |
HU Si-meng*,ZANG Shu-jie,WANG Qian,et al.
Vaccine knowledge and the influencing factors among pediatricians in China
[J]. CJPP, 2021, 36(5): 364-368.
|
[5] |
LU Xiao-qiong*,SHAN Guang-song,WANG Ben-zhen,et al.
Comparison of the value of transthoracic echocardiography and spiral CT coronary angiography in the follow-up of coronary artery lesions of Kawasaki disease
[J]. CJPP, 2021, 36(5): 382-386.
|
[6] |
XU Li,HE Sheng-nan,ZHANG Yu,et al.
Clinical study of juvenile rheumatic disease-associated macrophage activation syndrome:A retrospective study from a single center
[J]. CJPP, 2021, 36(4): 285-291.
|
[7] |
LIU Dan-dan,PAN Yue-na,JIAO An-xia,et al.
Epidemiological changes of pertussis before and after the use of vaccines
[J]. CJPP, 2020, 35(2): 157-162.
|
[8] |
Disease Prevention and Vaccination Group of Child Health Care Society of Chinese Preventive Medicine Association.
Expert consensus on the non-planned vaccination for children in special health status(I)——rotavirus vaccine
[J]. CJPP, 2020, 35(12): 913-917.
|
[9] |
Rheumatic Immunology Group of Pediatric Branch of Chinese Medical Doctor Association,China Children’s Immunity and Health Alliance,Editorial Committee of Chinese Journal of Practical Pediatrics.
Expert consensus on the diagnosis and treatment of macrophage activation syndrome related to childhood rheumatism(Ⅴ)— Kawasaki disease
[J]. CJPP, 2020, 35(11): 841-845.
|
[10] |
PAN Si-lin*,LIU Fang,LUO Gang.
Interpretation of Revision of Diagnostic Guidelines for Kawasaki Disease(6th revised edition)
[J]. CJPP, 2020, 35(11): 846-849.
|
[11] |
MENG Li*,LI Xiao-hui,LIU Jing-jing,et al.
Effect of aspirin on anti-platelet aggregation function in children with Kawasaki disease
[J]. CJPP, 2019, 34(8): 670-674.
|
[12] |
Suzhou Center for Disease Control and Prevention,Shanghai Municipal Center for Disease Control and Prevention,Hangzhou Center for Disease Control and Prevention,et al.
Expert consensus on immunization in children with special health state(ⅩⅩⅢ)——Allo-HSCT and immunization
[J]. CJPP, 2019, 34(7): 538-540.
|
[13] |
Center for Disease Control and Prevention in Shanghai,Center for Disease Control and Prevention in Hangzhou,Center for Disease Control and Prevention in Suzhou,et al.
Expert consensus on immunization in children with special health state(ⅩⅨ):immunosuppressive agents and immunization
[J]. CJPP, 2019, 34(5): 335-336.
|
[14] |
Center for Disease Control and Prevention in Shanghai,Center for Disease Control and Prevention in Hangzhou,Center for Disease Control and Prevention in Suzhou,et al.
Expert consensus on immunization in children with special health state(ⅩⅩ):immunization for children receiving intravenous immunoglobulin
[J]. CJPP, 2019, 34(5): 336-337.
|
[15] |
Center for Disease Control and Prevention in Suzhou,Center for Disease Control and Prevention in Shanghai,Center for Disease Control and Prevention in Hangzhou,et al.
Expert consensus on immunization in children with special health state(ⅩⅪ):inherited metabolic disease and immunization
[J]. CJPP, 2019, 34(5): 338-339.
|